Faculty of Sport Sciences, Division of Exercise Nutrition and Metabolism, Hacettepe University, 06800, Ankara, Turkey.
Eur J Appl Physiol. 2024 Jul;124(7):2111-2122. doi: 10.1007/s00421-024-05434-1. Epub 2024 Feb 29.
This study aimed to compare the effects of acute and multi-day low-dose sodium bicarbonate (SB) intake on high-intensity endurance exercise performance.
In a randomized, double-blind, cross-over design, twelve recreational male cyclists (age: 31.17 ± 4.91 years; Opeak: 47.98 ± 7.68 ml·kg·min) completed three endurance performance tests following acute SB (ASB, 0.2 g·kg SB), multi-day SB (MSB, 0.2 g·kg·day SB for four days), and placebo (PLA) intake. The high-intensity endurance performance was assessed with a cycling exercise test, wherein participants cycled on a bicycle ergometer at 95% of the predetermined anaerobic threshold for 30 min, followed by a time-to-exhaustion test at 110% of the anaerobic threshold. Data were analyzed using one-way and two-way repeated-measures ANOVA.
Significant main effects of supplementation protocol were evident in pre-exercise bicarbonate concentrations (F = 27.93; p < 0.01; partial eta squared (η) = 0.72; false discovery rate (FDR)-adjusted p value = 0.001). Prior to performance test, blood bicarbonate concentrations were significantly higher in MSB (25.78 ± 1.63 mmol·L[95% CI 26.55-28.44] (p < 0.001; FDR-adjusted p value = 0.001)) and ASB (27.49 ± 1.49 mmol·L [95% CI 24.75-26.81] (p < 0.001; FDR-adjusted p value = 0.007)) compared to PLA (23.75 ± 1.40 mmol·L [95% CI 22.86 to 24.64]). Time-to-exhaustion increased in MSB (54.27 ± 9.20 min [95% CI 48.43-60.12]) compared to PLA (49.75 ± 10.80 min [95% CI 42.89-56.62]) (p = 0.048); however, this increase in MSB did not reach the significance threshold of 1% FDR (FDR-adjusted p value = 0.040). No significant difference was noted in exhaustion times between ASB (51.15 ± 8.39 min [95% CI 45.82-56.48]) and PLA (p > 0.05).
Both acute and multi-day administration of low-dose SB improves buffering system in cyclists; nevertheless, neither intervention demonstrates sufficient efficacy in enhancing high-intensity endurance performance.
本研究旨在比较急性和多日低剂量碳酸氢钠(SB)摄入对高强度耐力运动表现的影响。
在一项随机、双盲、交叉设计中,12 名休闲男性自行车运动员(年龄:31.17±4.91 岁;Opeak:47.98±7.68ml·kg·min)在接受急性 SB(ASB,0.2g·kg SB)、多日 SB(MSB,0.2g·kg·day SB 连续四天)和安慰剂(PLA)摄入后完成了三项耐力表现测试。高强度耐力表现通过自行车运动测试进行评估,其中参与者在自行车测力计上以预定无氧阈的 95%强度骑行 30 分钟,然后以 110%无氧阈的时间进行至力竭测试。使用单向和双向重复测量方差分析对数据进行分析。
补充方案有显著的主效应,表现在运动前碳酸氢盐浓度上(F=27.93;p<0.01;部分 eta 平方(η)=0.72;错误发现率(FDR)调整后 p 值=0.001)。在进行表现测试前,MSB 组(25.78±1.63mmol·L[95%置信区间 26.55-28.44](p<0.001;FDR 调整后 p 值=0.001))和 ASB 组(27.49±1.49mmol·L[95%置信区间 24.75-26.81](p<0.001;FDR 调整后 p 值=0.007))的血碳酸氢盐浓度明显高于 PLA 组(23.75±1.40mmol·L[95%置信区间 22.86-24.64])。与 PLA 组(49.75±10.80min[95%置信区间 42.89-56.62])相比,MSB 组的力竭时间延长(54.27±9.20min[95%置信区间 48.43-60.12])(p=0.048);然而,这一在 MSB 中的增加并未达到 1% FDR 的显著阈值(FDR 调整后 p 值=0.040)。ASB 组(51.15±8.39min[95%置信区间 45.82-56.48])和 PLA 组之间的力竭时间无显著差异(p>0.05)。
急性和多日低剂量 SB 给药均可改善自行车运动员的缓冲系统;然而,两种干预措施均未显示出足够的增强高强度耐力表现的功效。